Stay updated on Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The clinical trial page displays the COSMIC-312 study record, including its design, participant criteria, interventions, outcome measures, and locations. It also includes results, record history, and study documents.
    Difference
    100%
    Check dated 2026-11-07T13:38:22.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:21:51.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A site-wide notice announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.” It appears above the 403 error page rather than providing study information.
    Difference
    1%
    Check dated 2026-10-24T14:59:24.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer’s site revision indicator changed from v3.7.1 to v3.7.2; the page remains a 403 error screen.
    Difference
    0.2%
    Check dated 2026-10-17T14:45:14.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The displayed site revision advances from v3.7.0 to v3.7.1 while the study page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T14:59:29.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page instead of the full study record, effectively blocking access to the COSMIC-312 trial information on that page.
    Difference
    18%
    Check dated 2026-09-19T18:56:43.000Z thumbnail image

Stay in the know with updates to Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.